About The Journal Open Access
Journal of Clinical Nephrology and Therapeutics is an open access, peer reviewed journal committed to publishing articles on all aspects of the advances in clinical research in Nephrology, Diabetic nephropathy, Pediatric nephrology, Renal physiology, Transplant medicine, Immunosuppression management, Intensive care nephrology, Ischemic nephropathy, Perioperative medicine etc.
Nephrology is the study of kidney physiology, kidney problems, the treatment and therapies of kidney problems and renal replacement therapy including dialysis and kidney transplantation, clinical nephropathy. Nephrology likewise concentrates on systemic conditions that influence the kidneys, like diabetes and immune system infection; and systemic diseases that happen because of kidney failure, like renal osteodystrophy and hypertension.
The journal functions as a platform that serves to bridge the gap between scientific explorations and findings, and implementing them for the development if clinically applicable medical tools and techniques. The Journal accepts original submissions in the form of research articles, review articles, short communications, opinion articles, case reports, letters to the Editor, commentaries, image articles, book reviews, perspective etc.
You may submit manuscripts online at: www.scholarscentral.org/submission/clincal-nephrology-therapeutics.html or you may send the article as an email attachment to the following mail-id: nephrology@esciencejournals.org
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Clinical nephrology and therapautics is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
h-index
Articles published in Journal of Clinical Nephrology and Therapeutics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Nephrology and Therapeutics has got h-index 2 , which means every article in Journal of Clinical Nephrology and Therapeutics has got 2 average citations.
editorialservice@alliedacademies.org
Just Published Articles View More
Editorial August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Exploring the Relationship Between Sleep Apnea and Chronic Kidney Disease Progression
Robinson Siebeck*
DOI:
Opinion Article August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Role of Hyperuricemia in the Development and Progression of Chronic Kidney Disease
Stacy Jawadi*
DOI:
Editorial August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Influence of Gender Differences on Kidney Disease Progression and Treatment Response
Hilda Aslamzai*
DOI:
Editorial August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Effect of Fluid Overload on Mortality and Morbidity in Hemodialysis Patients
Simone Jamil*
DOI:
Opinion Article August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Novel Antifibrotic Agents in the Treatment of Diabetic Nephropathy: A Clinical Trial Analysis
Avinash Yahiya*
DOI:
Brief Report August 26, 2024
P.1-2
J Clin Nephrol Ther: 8(4): 1-2
Impact of COVID-19 on Kidney Function and Long-Term Renal Health: A Clinical Study
Benjamin Xin*
DOI: